73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Turbocharging the body's natural killer cells to defeat cancer

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth
How do metastatic tumor cells grow in lymph nodes?

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty
Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor
Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show
Living alone doesn't have to mean being lonely, says study

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un
Study links gut microbiome and aggressive prostate cancer

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su
Researchers reveal key mechanism of natural killer cell dysfunction

Researchers reveal key mechanism of natural killer cell dysfunction

by Liu Jia,Chinese Academy of SciencesIntratumoral NK cells lack abundant membrane protrusions. Credit:Nature Immunology(2023). DOI: 10.1038/s41590-023-01462-9A team has revealed the

Researchers reveal key mechanism of natural killer cell dysfunction

by Liu Jia,Chinese Academy of SciencesIntratumoral NK cells lack abundant membrane protrusions. Credit:Nature Immunology(2023). DOI: 10.1038/s41590-023-01462-9A team has revealed the
Possible new cancer treatment target discovered

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers
Adding vaccine to immunotherapy for liver cancer shows promise in early trial

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh
T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t
New study shows more deaths with cancer as contributing cause during first year of pandemic

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc
New study helps explain the anti-cancer properties of mannose sugar

New study helps explain the anti-cancer properties of mannose sugar

bySanford Burnham Prebys Medical Discovery InstituteProposed model for the mechanism underlying anticancer activity of mannose in mannose phosphate isomerase knockout (MPI-KO) human cancer cells

New study helps explain the anti-cancer properties of mannose sugar

bySanford Burnham Prebys Medical Discovery InstituteProposed model for the mechanism underlying anticancer activity of mannose in mannose phosphate isomerase knockout (MPI-KO) human cancer cells